Online discussions on the merits of alternative medicine can get quite heated. And its proponents, given enough time, will inevitably cite the same drug as “evidence” of the failings of science. Call it Gavura’s Law, with apologies to Mike Godwin:
As an online discussion on the effectiveness of alternative medicine grows longer, the probability that thalidomide will be cited approaches one.
A recent comment on my own blog, regarding the homeopathic product Traumeel, is typical:
If the scientific method is all that separates an accepted claim, ie Thalidomide, Vioxx, Bextra, Darvon, from mere anecdote, of what benefit is the Science?
As a non-scientist consumer, I’ll take the anecdotes and my own experience. Thank you.
If scientists want to be taken seriously, they must stop selling themselves to the highest bidder becoming corporate whores without a shred of decency. To my mind, that’s how the claims for Thalidomide, Vioxx, Bextra, Darvon were accepted, making the scientific method utterly worthless.
To this commenter, “science has been wrong before.” And that invalidates science, and apparently validates homeopathy. It’s a fallacious argument. But does thalidomide actually represent a failing of science-based medicine? No, not even close. It’s so wrong, it’s not even wrong. Thalidomide is good example of the importance of science-based medicine and why allowing alternative medicine to be sold in the absence of good science is a concern.
The broad strokes of thalidomide causing thousands of birth defects are well known. But the details are important to understand the implications to regulation, and to science-based medicine, today.
Thalidomide was first marketed in 1958 in Germany by Chemie Grünenthal. While its developmental origins are somewhat unclear, it was initially marketed as a treatment for seizures, and later as an anti-nauseant and sedative. At the time, barbiturates were frequently used as sedatives. And compared to barbiturates, which were highly toxic in overdose, thalidomide was well tolerated, even in overdose. Based on its apparent safety, no prescription was required. Eventually its attractiveness as an anti-nauseant led to its use in pregnancy for morning sickness.
It wasn’t known at the time, but fetal exposure to thalidomide between days 35 and 48 was causing severe limb and organ defects in 20-30% of children. In the 1950′s it wasn’t even recognized that drugs could cross the placenta and cause adverse effects to the fetus. Thalidomide hadn’t been tested on pregnant animals prior to marketing for use in pregnancy. Regulators didn’t require it. And the consequences were horrific.
Thalidomide became a popular drug because of its apparent safety and effectiveness, and it was marketed alone and in combination with other drugs in Germany, the UK, Canada, and other countries. But within a few years, babies started being born with characteristic limb and organ deformities. In 1961, two independent researchers identified thalidomide as the likely causal agent. The manufacturer sought to undermine and discredit the findings, but it was clear – the drug had caused catastrophic harm to thousands of fetuses. Subsequent animal testing confirmed this.
The USA largely escaped the thalidomide tragedy – due to stronger regulations, and the action of a single employee.
American drug regulations have evolved over time. The Pure Food and Drugs Act (1906) did not require that drugs be tested for safety and efficacy before sale. It was the regulator’s responsibility to demonstrate a product was unsafe. In 1938, the S.E. Massengill company manufactured a liquid version antibiotic sulfanilamide, mixing it with diethylene glycol -a poison more commonly used as antifreeze. When patients started dying, a massive recall was implemented – but not before over 100 people died. The tragedy brought about significant reforms to drug regulations in the form of the Food, Drugs and Cosmetics Act (1938) that required manufacturers to obtain FDA approval for any drug sold, prior to any sale.
Frances Oldham Kelsey was a reviewer with the FDA in 1960, and was responsible for evaluating the thalidomide marketing application. Kelsey refused to approve the drug in the absence of safety data. Her concern was peripheral neuropathy – not teratogenicity, which wasn’t even considered at the time. She described the application process in a paper she published in 1965:
The New Drug Application for thalidomide was presented in September, 1960. The drug had been marketed in Germany since 1957 where it was available without prescription, and in Great Britain since 1958. However, it was felt that the evidence submitted in the application was not adequate to indicate the safety of the drug. In particular, although this drug appeared to be remarkably nontoxic in animals and human beings, little or no information was available concerning its absorption, distribution in the body, or its excretion. Since the possibility existed that the low toxicity of the drug in certain species might be related to poor absorption in those species, and that under certain conditions the absorption in other species might be increased, further work was requested relative to the metabolism of the drug.
As the FDA studied the side effect profile, the teratogenicity of the drug became clear as and the application for licensure was discontinued. Kelsey was hailed as hero. Yet despite the refusal to formally approve the product for sale, millions of doses had been administered as part of “clinical trials” (in name only). Yet due to Kelsey’s refusal to approve the drug, the drug was not widely used, and only 17 children were born in the USA with thaldomide-induced effects.
Regulators worldwide acted to ensure another thalidomide tragedy would not occur. In 1962 the Kefauver-Harris Drug Amendments were passed, increasing the rigor of the drug approval process, requiring the demonstration of safety and effectiveness via objectively designed and executed clinical trials. These amendments also implemented the requirement for adequate preclinical trials before any human studies, including animal studies to evaluate fetal risks. Marketing requirements were also implemented, restricting manufacturers from making unfounded, unsubstantiated claims of safety and efficacy. Finally, the amendments ushered in the requirement for manufacturers to collect and report all adverse events associated with drug use – measures designed to capture any events not otherwise identified in pre-marketing clinical trials. Similar actions occurred in other countries. Today, over 100 countries now collaborate with the World Health Organization to pool adverse event reporting and look for signals of drug harms.
The worldwide disaster of thalidomide led to most of the current framework we have in place today to evaluate the safety and efficacy of drug products. Ironically, these are the same requirements that manufacturers of supplements and other “alternative” medicine products have been largely successful in circumventing. In the USA, it’s DSHEA, which (as blogged about regularly at SBM) removed the onus of demonstrating safety and efficacy from the manufacturer and put the requirement to demonstrate harm on the FDA – exactly the same scenario as drugs in the early 1900′s. In Canada, the Natural Health Product regulations has introduced a lowered bar for non-drug supplements: Today even homeopathic remedies are deemed safe and effective and approved with unique recommended uses.
The Resurrection of Thalidomide
Almost 30 years after thalidomide was withdrawn, it’s back on the market in the United States, Canada and many other countries. It’s been found to be effective for a number of conditions including erythema nodosum leprosum, multiple myeloma, and is being investigated for efficacy in an array of other conditions. There’s an analog of thalidomide now marketed, lenalidomide, also used to treat cancer. To minimize the teratogenicity risk, intensive programs are in place to minimize any possibility of use in pregnancy. So while the drug has known harms, it seems to be highly effective for some medical conditions where few effective alternatives exist. Access, therefore, is based on a careful evaluation of the risks and benefits.
Does Thalidomide Invalidate Science-Based Medicine?
Cases like thalidomide provide a good example of why SBM authors argue against regulatory double-standards, and advocate for a single, science-based standard for evaluating all products: drugs as well as supplements. There is no intrinsic reason to think any product, regardless of its source, is safe or effective – we must evaluate it, objectively. Thalidomide’s history is a cautionary tale reminding us that assumptions without good evidence can lead to terrible consequences.
And that leads to the logical fallacies that the thalidomide retort represents. Thalidomide is an effective drug for some conditions – but it is a teratogen. It’s not alone in this regard – other drugs have been identified as teratogens. The sale of any drug is based on an evaluation of the known benefits and risks.And getting back to the comment I received at the top, those that support alternative medicine will reject the science-based approach: This is the system that gave us thalidomide (and Vioxx, etc). Therefore, it’s a failure, and we should reject it. This is the perfect solution fallacy.
Admittedly, medicine is not perfect. Regulators don’t identify all the harms before a drug is licensed. Drug manufacturers can behave badly. And drugs don’t always work the way we want them to, and they can cause harms. They commenter I cite above took objection to an evaluation of homeopathy. Yes, homeopathy has no toxic side effects (usually) and causes no teratogenicity – but it also has no demonstrated efficacy beyond placebo effects. The harms and problems of science-based approaches add no support to the efficacy claims of any alternative medicine system. Homeopathy, acupuncture, and reiki don’t become effective because drugs can have side effects. SBM may not be perfect, but it delivers the goods.
More generally, comparing science-based medicine to any alternative medical system a is false dichotomy. Unlike the different alternative medicine systems (homeopathy, naturopathy, reiki, etc) which are typically based around a fixed set of rules, the only thing that science-based medicine interventions have is common is that they work. SBM is not immutable to change – treatment shown to be safe and effective become medicine, and those that are not, are discarded. So although thalidomide causes birth defects, it is also an effective medication when used properly. We don’t have to make a choice between a system that produced drugs that cause birth defects, and alternative medicine. We choose to use treatments where the expected benefits outweigh the known risks.
Citing thalidomide as an argument against science-based approaches is also a straw man argument. The way drugs are regulated today bears little resemblance today to when thalidomide was licensed and sold. Safety standards are far more rigorous, in part because of the lesson of thalidomide. Today, the only products that are not subject to these same strict safety and efficacy standards are usually the alternative medicine treatments.
Citing thalidomide is also an appeal to fear. We hear the word and we immediately think of children born with birth defects. We don’t want that to happen. But like the perfect solution fallacy, the catastrophic side effects of thalidomide in pregnancy add no merit to to claims of efficacy of any alternative medicine treatment or system. We still need the evidence.
Thalidomide was a very real tragedy with a huge human cost. It’s most important lesson is that assumptions of safety and efficacy, in the absence of evidence, can be catastrophic. Citing thalidomide as a a reason to reject science-based medicine is not only fallacious, it reflects a fundamental lack of understanding of the lessons learned.
- SoutheastHEALTH, Washington University School of Medicine announce collaboration - Southeast Missourian - February 24th, 2017
- The best medicine for ADHD might not be medicine, at least at first - Washington Post - February 24th, 2017
- Chutes & Ladders: FDA's personalized medicine head leaves for Grail - FierceBiotech - February 24th, 2017
- Jen Widerstrom's Medicine Ball Workout Will Get You Toned from Head to Toe - Health.com - February 24th, 2017
- Shinyribs Has Got Your Medicine - Texas Monthly - February 24th, 2017
- Wellness Family Medicine closes after doctor's license suspended - Spartanburg Herald Journal - February 24th, 2017
- Incredible Medicine: Dr Weston's Casebook is a watchable series about cutting-edge medical science: review - Telegraph.co.uk - February 23rd, 2017
- The Brilliant Drone That'll Deliver MedicineThen Rot Away | WIRED - WIRED - February 23rd, 2017
- The Future of Medicine is Artificial Intelligences And a Virtual World - Futurism - February 23rd, 2017
- NBCBLK28: Christen Johnson is Pushing For Diversity In Medicine - NBCNews.com - February 23rd, 2017
- Medicine Hat mumps outbreak prompts alert as virus hits hockey team - CBC.ca - February 23rd, 2017
- New facility brings together fitness, wellness and medicine - Orlando Sentinel - February 23rd, 2017
- Red Deer man arrested in Medicine Hat drug bust - rdnewsnow.com - February 23rd, 2017
- Stanford Medicine magazine looks at what arts, humanities bring to ... - Stanford Medical Center Report - February 22nd, 2017
- Anti-epilepsy medicine taken by pregnant women does not harm the ... - Science Daily - February 22nd, 2017
- Lisa K. Nolan named dean of UGA College of Veterinary Medicine - Online Athens - February 22nd, 2017
- Old Crow Medicine Show Ready Bob Dylan Tribute Album - Rolling ... - RollingStone.com - February 22nd, 2017
- Benefits to having a family physician, promoting family medicine week - UpperMichigansSource.com - February 22nd, 2017
- Jeffrey V. Ravetch receives 2017 Ross Prize in Molecular Medicine - The Rockefeller University Newswire - February 22nd, 2017
- CU collaboration produces health 'game-changer' - CU Anschutz Today (press release) - February 22nd, 2017
- Home | New York Academy of Medicine - February 21st, 2017
- Cincy students get a glimpse into medicine - Cincinnati.com - February 21st, 2017
- Virginia Board of Medicine adopts regulations to address opioid epidemic - WRIC - February 21st, 2017
- Clemson researchers work toward brighter future in medicine, security - Greenville News - February 21st, 2017
- What it's like in preventive medicine: Shadowing Dr. Blumenthal - American Medical Association (blog) - February 21st, 2017
- Holistic medicine, what you need to know - Arizona Sonoro News - February 20th, 2017
- New provider joins Samaritan Lebanon Health Center Family Medicine clinic - Lebanon Express - February 20th, 2017
- Precision medicine's Holy Grail: Anticipate cancer's next step - Healthcare IT News - February 20th, 2017
- 3D-printed prosthetic limbs: the next revolution in medicine - The Guardian - February 20th, 2017
- Definitions relating to regenerative medicine studies at the Steadman Philippon Research Institute - The Denver Post - February 20th, 2017
- Dr. David Katz, Preventative Medicine: Diet Trial Tribulations - New Haven Register - February 20th, 2017
- Dear Sports Medicine Counsel #4 - The Argus.ca - February 20th, 2017
- Smartphones are revolutionizing medicine - Phys.Org - February 18th, 2017
- Request For Abstracts: The Practice Of Medicine - Health Affairs (blog) - February 18th, 2017
- Slow Medicine: Good Reads - MedPage Today (blog) - February 18th, 2017
- Was Andy Cohen the Shadiest Person at the Married to Medicine Reunion? 5 Fierce Moments You Need to Check Out - Bravo (blog) - February 18th, 2017
- Family Medicine Faculty More Diverse Than Most, but Still Wanting - AAFP News - February 18th, 2017
- Medicine Hat unveils proposal to assist residents dealing with poverty - The Globe and Mail - February 18th, 2017
- Married to Medicine's Quad Webb-Lunceford Aims to Prove She's ... - E! Online - February 18th, 2017
- Mercy Health joins forces with Michigan Medicine - Grand Haven Tribune - February 17th, 2017
- Maine's HealthInfoNet taps Orion Health for precision medicine platform - Healthcare IT News - February 17th, 2017
- Hospitals, Hospital Medicine, And Health For All - Health Affairs (blog) - February 16th, 2017
- Medicine Rocks State Park - Atlas Obscura - February 16th, 2017
- What a dying patient taught me about the limits of medicine - Crain's Chicago Business - February 16th, 2017
- Five-day fasting diet could fight disease, slow aging - Science Magazine - February 16th, 2017
- Medicine: Discovery through doing - Nature.com - February 16th, 2017
- Brookhaven Police offer medicine disposal collection unit - Atlanta Journal Constitution - February 16th, 2017
- A Canadian City Thrives on Gas, Like a 'Wealthy Little Country' - New York Times - February 16th, 2017
- Paul Ryan: Democrats Want To Go Down 'Socialized Medicine Path' - TPM - February 16th, 2017
- Why Fortress Investment Group, Editas Medicine, and Hertz Global Holdings Jumped Today - Motley Fool - February 16th, 2017
- Capitalism, race and medicine are topics this spring at Crispus Attucks Community Academy - LancasterOnline - February 16th, 2017
- The Daily Pennsylvanian | Penn Medicine has developed a vaccine ... - The Daily Pennsylvanian - February 15th, 2017
- Mt. Sinai Merger Shuts New York's Integrative Medicine "Crown Jewel" - Huffington Post - February 15th, 2017
- UI teaching future doctors the business of medicine - Iowa City Press Citizen - February 15th, 2017
- Virdis Medicine comes to Chambersburg Town Hall meeting to inform residents about their company - WHAG - February 15th, 2017
- Chambersburg Council hears a presentation from Virdis Medicine at Monday's council meeting - WHAG - February 14th, 2017
- Dr. Virginia Apgar: Changing perceptions in medicine - Medical News Today - February 13th, 2017
- This medicine-toting drone flew where no one thought it could - CNET - February 13th, 2017
- 'Women With Heart' to advocate for Volunteers in Medicine - Florida Times-Union - February 13th, 2017
- Corn, milk proteins make medicine easier to swallow -- ScienceDaily - Science Daily - February 13th, 2017
- HIMSS Precision Medicine Summit: Call-for-presentations now open - Healthcare IT News - February 13th, 2017
- The Father of Electrical Medicine - San Francisco Examiner - February 12th, 2017
- Medicine flourishing in Lilac City - The Columbian - February 12th, 2017
- Medicine turns to solar energy - Rutland Herald - February 11th, 2017
- DC Surgeon Says His Journey to Medicine is One of Survival - NBC4 Washington - February 11th, 2017
- Russia delivers over 200kg of medicine to Latakia amidst US-led ... - AMN Al-Masdar News (registration) - February 11th, 2017
- Food and medicine shortages weren't bad enough. Now Venezuelans can't even get passports. - Miami Herald - February 11th, 2017
- What's Race Got to Do with Medicine? - NPR - February 10th, 2017
- When Does Medicine Leave Women Behind? - NPR - February 10th, 2017
- Call for Presentations: HIMSS Precision Medicine Summit - MobiHealthNews - February 10th, 2017
- Laser-based camera improves view of the carotid artery - University of Michigan Health System News (press release) - February 10th, 2017
- Dog owners blame popular flea medicine for pets' deaths - KIRO Seattle - February 10th, 2017
- PMDA Head Talks Priorities for 'Rational Medicine' - Regulatory Focus - February 10th, 2017
- What Will Next-Stage Digital Medicine Look Like? - KQED - February 9th, 2017
- Summa emergency medicine residency loses accreditation, health system put on probation - Crain's Cleveland Business - February 9th, 2017
- At least five patients accidentally infected with HIV at traditional Chinese medicine hospital - The Independent - February 9th, 2017
- FDA's Personalized Medicine Leader Leaving for Liquid Biopsy Startup Grail - GenomeWeb - February 9th, 2017
- This travel medicine doctor is always on the go - The Boston Globe - February 9th, 2017
- McLeod Sports Medicine offers free Performance Clinic - WBTW - Myrtle Beach and Florence SC - February 9th, 2017
- Three of my colleagues have killed themselves. Medicine's dark secret can't go on - The Sydney Morning Herald - February 9th, 2017